Johnson & Johnson Total Liabilities 2010-2024 | JNJ

Johnson & Johnson total liabilities for the quarter ending December 31, 2024 were $108.614B, a 9.95% increase year-over-year.

  • Johnson & Johnson total liabilities for 2024 were $108.614B, a 9.95% increase from 2023.
  • Johnson & Johnson total liabilities for 2023 were $98.784B, a 10.66% decline from 2022.
  • Johnson & Johnson total liabilities for 2022 were $110.574B, a 2.39% increase from 2021.

Johnson & Johnson Total Liabilities 2010-2024 | JNJ

  • Johnson & Johnson total liabilities for 2024 were $108.614B, a 9.95% increase from 2023.
  • Johnson & Johnson total liabilities for 2023 were $98.784B, a 10.66% decline from 2022.
  • Johnson & Johnson total liabilities for 2022 were $110.574B, a 2.39% increase from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$823.1B
Novo Nordisk (NVO)$374.3B
AbbVie (ABBV)$348.4B
Roche Holding AG (RHHBY)$259.5B
Novartis AG (NVS)$218.5B
Merck (MRK)$216.5B
Pfizer (PFE)$146.7B
Sanofi (SNY)$136B
Bayer (BAYRY)$22B
Innoviva (INVA)$1.1B